Search This Blog

Wednesday, July 31, 2019

Theravance Biopharma EPS beats by $0.50, beats on revenue

Theravance Biopharma (NASDAQ:TBPH): Q2 GAAP EPS of -$0.72 beats by $0.50.
Revenue of $26.15M (+11.4% Y/Y) beats by $14.22M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)